• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病中三核苷酸重复序列长度不稳定性与发病年龄

Trinucleotide repeat length instability and age of onset in Huntington's disease.

作者信息

Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M

机构信息

Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown 02129.

出版信息

Nat Genet. 1993 Aug;4(4):387-92. doi: 10.1038/ng0893-387.

DOI:10.1038/ng0893-387
PMID:8401587
Abstract

The initial observation of an expanded and unstable trinucleotide repeat in the Huntington's disease gene has now been confirmed and extended in 150 independent Huntington's disease families. HD chromosomes contained 37-86 repeat units, whereas normal chromosomes displayed 11-34 repeats. The HD repeat length was inversely correlated with the age of onset of the disorder. The HD repeat was unstable in more than 80% of meiotic transmissions showing both increases and decreases in size with the largest increases occurring in paternal transmissions. The targeting of spermatogenesis as a particular source of repeat instability is reflected in the repeat distribution of HD sperm DNA. The analysis of the length and instability of individual repeats in members of these families has profound implications for presymptomatic diagnosis.

摘要

亨廷顿舞蹈病基因中三核苷酸重复序列的扩展和不稳定最初被观察到,现在已在150个独立的亨廷顿舞蹈病家族中得到证实和扩展。亨廷顿舞蹈病(HD)染色体含有37 - 86个重复单位,而正常染色体显示有11 - 34个重复。HD重复序列长度与疾病发病年龄呈负相关。在超过80%的减数分裂传递中,HD重复序列是不稳定的,其大小既有增加也有减少,其中最大的增加发生在父系传递中。将精子发生作为重复序列不稳定的一个特殊来源,这一点在HD精子DNA的重复序列分布中得到体现。对这些家族成员中单个重复序列的长度和不稳定性进行分析,对症状前诊断具有深远意义。

相似文献

1
Trinucleotide repeat length instability and age of onset in Huntington's disease.亨廷顿病中三核苷酸重复序列长度不稳定性与发病年龄
Nat Genet. 1993 Aug;4(4):387-92. doi: 10.1038/ng0893-387.
2
[Molecular genetics of Huntington's disease].[亨廷顿舞蹈症的分子遗传学]
Rinsho Shinkeigaku. 1995 Dec;35(12):1529-31.
3
Trinucleotide repeat length and rate of progression of Huntington's disease.亨廷顿舞蹈症的三核苷酸重复序列长度与疾病进展速率
Ann Neurol. 1994 Oct;36(4):630-5. doi: 10.1002/ana.410360412.
4
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.三核苷酸(CAG)重复序列长度与亨廷顿舞蹈症临床特征之间的关系。
Nat Genet. 1993 Aug;4(4):398-403. doi: 10.1038/ng0893-398.
5
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.亨廷顿舞蹈病中三核苷酸重复序列扩增与表型变异的关系。
Nat Genet. 1993 Aug;4(4):393-7. doi: 10.1038/ng0893-393.
6
De novo expansion of a (CAG)n repeat in sporadic Huntington's disease.散发性亨廷顿舞蹈病中(CAG)n重复序列的从头扩增
Nat Genet. 1993 Oct;5(2):168-73. doi: 10.1038/ng1093-168.
7
[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].[三核苷酸重复扩增数目在亨廷顿舞蹈病临床表现中的重要性]
Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82.
8
[Huntington's chorea: clinical aspects, genetics and current diagnosis].[亨廷顿舞蹈症:临床症状、遗传学及当前诊断方法]
Ther Umsch. 1995 Dec;52(12):814-20.
9
[Molecular diagnosis of Huntington's disease: an analysis of two large families].[亨廷顿舞蹈病的分子诊断:两个大家族的分析]
Zhonghua Yi Xue Za Zhi. 1995 Nov;75(11):689-93, 711-2.
10
A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.一种针对三核苷酸重复序列的新型聚合酶链反应(PCR)检测方法,该三核苷酸重复序列在亨廷顿病染色体上不稳定且会发生扩增。
Mol Cell Probes. 1993 Jun;7(3):235-9. doi: 10.1006/mcpr.1993.1034.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion.亨廷顿舞蹈症连接酶1修饰变体可提高连接酶保真度并抑制体细胞中CAG重复序列的扩增。
bioRxiv. 2025 Jul 18:2025.07.15.664798. doi: 10.1101/2025.07.15.664798.
3
Loss of FIC-1-mediated AMPylation activates the UPRER and upregulates cytosolic HSP70 chaperones to suppress polyglutamine toxicity.
FIC-1介导的AMP化作用丧失会激活内质网未折叠蛋白反应(UPRER)并上调胞质热休克蛋白70(HSP70)伴侣蛋白,以抑制多聚谷氨酰胺毒性。
PLoS Genet. 2025 Jun 13;21(6):e1011723. doi: 10.1371/journal.pgen.1011723. eCollection 2025 Jun.
4
Navigating the neuronal recycling bin: Another look at huntingtin in coordinating autophagy.探索神经元“回收箱”:重新审视亨廷顿蛋白在协调自噬中的作用
Autophagy Rep. 2025 Jun 2;4(1):2472450. doi: 10.1080/27694127.2025.2472450. eCollection 2025.
5
Transient Interdomain Interactions Modulate the Monomeric Structural Ensemble and Self-Assembly of Huntingtin Exon 1.瞬时结构域间相互作用调节亨廷顿蛋白外显子1的单体结构集合和自组装。
Adv Sci (Weinh). 2025 Apr 28:e2501462. doi: 10.1002/advs.202501462.
6
CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology.细胞功能综合分析工具(CellFIE):将通路发现与扰动的集中分析相结合,揭示亨廷顿病的通路,包括神经元发育和形态的遗传修饰因子。
bioRxiv. 2025 Feb 22:2025.02.19.639023. doi: 10.1101/2025.02.19.639023.
7
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials.G9a:神经退行性疾病的一种表观遗传治疗策略——从靶点发现到临床试验
Med Res Rev. 2025 May;45(3):985-1015. doi: 10.1002/med.22096. Epub 2025 Jan 6.
8
Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays.突变亨廷顿蛋白随CAG重复序列扩增而减少:对治疗学和生物测定的意义。
Brain Commun. 2024 Nov 15;6(6):fcae410. doi: 10.1093/braincomms/fcae410. eCollection 2024.
9
Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding.通过转录抑制和直接CAG重复序列结合抑制亨廷顿舞蹈病的体细胞不稳定性
bioRxiv. 2024 Nov 4:2024.11.04.619693. doi: 10.1101/2024.11.04.619693.
10
Medication Use and Treatment Indications in Huntington's Disease; Analyses from a Large Cohort.亨廷顿舞蹈症的药物使用与治疗指征;来自一个大型队列的分析
Mov Disord Clin Pract. 2024 Dec;11(12):1530-1541. doi: 10.1002/mdc3.14230. Epub 2024 Oct 21.